Nicolas Janin

2.9k total citations
40 papers, 1.5k citations indexed

About

Nicolas Janin is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Nicolas Janin has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Nicolas Janin's work include DNA Repair Mechanisms (9 papers), Cancer-related Molecular Pathways (9 papers) and BRCA gene mutations in cancer (7 papers). Nicolas Janin is often cited by papers focused on DNA Repair Mechanisms (9 papers), Cancer-related Molecular Pathways (9 papers) and BRCA gene mutations in cancer (7 papers). Nicolas Janin collaborates with scholars based in France, Belgium and Germany. Nicolas Janin's co-authors include Brigitte Bressac–de Paillerets, Katia Ossian, Dominique Stoppa‐Lyonnet, Nadine Andrieu, Anthony Laugé, C Griscelli, Alain Aurias, L. Kayitalire, Étienne Brain and E Antoine and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Nicolas Janin

36 papers receiving 1.5k citations

Peers

Nicolas Janin
Gloria Balaban United States
Ajay K. Malik United States
A. Thomas Look United States
Z Stasková Czechia
B. Zbar United States
Harry C. Hwang United States
P. Worst Germany
Gloria Balaban United States
Nicolas Janin
Citations per year, relative to Nicolas Janin Nicolas Janin (= 1×) peers Gloria Balaban

Countries citing papers authored by Nicolas Janin

Since Specialization
Citations

This map shows the geographic impact of Nicolas Janin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Janin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Janin more than expected).

Fields of papers citing papers by Nicolas Janin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Janin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Janin. The network helps show where Nicolas Janin may publish in the future.

Co-authorship network of co-authors of Nicolas Janin

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Janin. A scholar is included among the top collaborators of Nicolas Janin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Janin. Nicolas Janin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janin, Nicolas, et al.. (2022). Rapid-onset paraneoplastic cerebellar degeneration successfully treated by radiotherapy and tumorectomy. International Cancer Conference Journal. 12(1). 19–23.
2.
Robays, Jo, Sabine Stordeur, Tom Van Maerken, et al.. (2015). Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li-Fraumeni syndrome and Cowden syndrome. 1 indexed citations
3.
Brakeleer, Sylvia De, Jacques De Grève, Remy Loris, et al.. (2010). Cancer predisposing missense and protein truncatingBARD1mutations in non-BRCA1orBRCA2breast cancer families. Human Mutation. 31(3). E1175–E1185. 68 indexed citations
4.
Mutesa, Léon, Geneviève Pierquin, Nicolas Janin, et al.. (2008). Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors. Cancer Genetics and Cytogenetics. 182(1). 40–42. 22 indexed citations
5.
Monnerat, Christian, Agnès Chompret, Caroline Kannengiesser, et al.. (2007). BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma. Familial Cancer. 6(4). 453–461. 30 indexed citations
6.
Segers, Kurt, François‐Charles Wang, Nicolas Janin, et al.. (2007). Novel SACS mutation in a Belgian family with sacsin-related ataxia. Journal of the Neurological Sciences. 264(1-2). 73–76. 30 indexed citations
7.
Andrieu, Nadine, Anthony Laugé, Katia Ossian, et al.. (2005). Ataxia-Telangiectasia genes and breast cancer risk in a French family study. Journal of Dairy Research. 72(S1). 73–80. 7 indexed citations
8.
Aouba, A., et al.. (2003). Le syndrome de Pourfour du Petit : une cause rare d’exophtalmie unilatérale avec mydriase et élargissement de la fente palpébrale. La Revue de Médecine Interne. 24(4). 261–265. 10 indexed citations
9.
Geoffroy-Perez, B., Nicolas Janin, Katia Ossian, et al.. (2002). Variation in breast cancer risk of heterozygotes for ataxia‐telangiectasia according to environmental factors. International Journal of Cancer. 99(4). 619–623. 12 indexed citations
10.
Vega, Ana, Berta Campos, Brigitte Bressac–de Paillerets, et al.. (2001). The R71GBRCA1is a founder Spanish mutation and leads to aberrant splicing of the transcript. Human Mutation. 17(6). 520–521. 92 indexed citations
11.
Geoffroy-Perez, B., Nicolas Janin, Katia Ossian, et al.. (2001). Cancer risk in heterozygotes for ataxia-telangiectasia. International Journal of Cancer. 93(2). 288–293. 99 indexed citations
12.
Janin, Nicolas, Nadine Andrieu, Katia Ossian, et al.. (1999). Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. British Journal of Cancer. 80(7). 1042–1045. 78 indexed citations
13.
Janin, Nicolas. (1999). A Simple Model for Carcinogenesis of Colorectal Cancers with Microsatellite Instability. Advances in cancer research. 77. 189–221. 18 indexed citations
14.
Cesne, Axel Le, E Antoine, M. Spielmann, et al.. (1995). High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.. Journal of Clinical Oncology. 13(7). 1600–1608. 162 indexed citations
15.
Lubin, Richard, Thierry Soussi, Vladimir Lazar, et al.. (1995). Primary proliferative T cell response to wild‐type p53 protein in patients with breast cancer. European Journal of Immunology. 25(6). 1765–1769. 89 indexed citations
16.
Janin, Nicolas. (1995). Prédisposition génétique au cancer. La Revue de Médecine Interne. 16(7). 500–517.
17.
Blanchet‐Bardon, C, Lutz Langbein, S A Narod, et al.. (1994). Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer. Nature Genetics. 6(1). 106–110. 97 indexed citations
18.
Janin, Nicolas. (1994). Introduction au processus de la cancérogenèse : les cancers sont des maladies génétiques somatiques. La Revue de Médecine Interne. 15(12). 821–829. 1 indexed citations
19.
Kaplan, Josseline, S. Gerber, Dominique Larget‐Piet, et al.. (1993). A gene for Stargardt's disease (fundus flavimaculatus) maps to the short arm of chromosome 1. Nature Genetics. 5(3). 308–311. 130 indexed citations
20.
Janin, Nicolas, et al.. (1992). PCR-assisted localization of the human SRPR gene. Human Genetics. 88(5). 583–585. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026